Skip to main content

US ClosedU.S. Closed

ACAD: ACADIA Pharmaceuticals Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

ACADIA Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics.

52W Range

84thpctl

Volume

0.95×avg

Market Cap

4.98BUSD

P/E Ratio

12.9TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

ACADIA Pharmaceuticals Inc.

ACADNASDAQ Global Select·USD·Closed

ACADIA Pharmaceuticals Inc.

ACADNASDAQ·USD·Closed

$29.11

−2.09%

$29.11

−$0.62 (2.09%)

52W Range

84thpctl

Volume

0.95×avg

Mkt Cap

4.98BUSD

P/E

12.9TTM

Div Yield

–ann